Cardiovascular complications in type 1 diabetes mellitus;Complications cardiovasculaires du diabète de type 1

Diabetes and Metabolism

Volumn 36, Issue 5, 2010, Pages 341-344

  Brindisi, M C ^a   Bouillet, B ^a   Verges B ^a   Halimi, S ^b  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Arrhythmia; Atherosclerosis; Cardiovascular disease; Detection; Review; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES CONTROL; ELECTROCARDIOGRAPHY MONITORING; HEART ARRHYTHMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PHYSICAL ACTIVITY; QT PROLONGATION; REVIEW;

ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; ELECTROCARDIOGRAPHY; EXERCISE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; LIPIDS; MALE; RISK FACTORS;

EID: 78649451983     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.06.002     Document Type: Review

References (19)

1. Nathan D.M., Zinman B., Cleary P.A., Backlund J.Y.C., Genuth S., Miller M., et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch Intern Med 2009, 169:1307-1316. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group.
2. Pambianco G., Costacou T., Ellis D., Becker D.J., Klein R., Orchard T.J. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 2006, 55:1463-1469.
3. Laing S.P., Swerdlow A.J., Slater S.D., Burden A.C., Morris A., Waugh N.R., et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003, 46:760-765.
4. Larsen J., Brekke M., Sandvik L., Arnesen H., Hanssen K.F., Dahl-Jorgensen K. Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes 2002, 51:2637-2641.
5. Hodis H.N., Mack W.J., LaBree L., Selzer R.H., Liu C.R., Azen S.P. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998, 128:262-269.
6. Larsen J.R., Brekke M., Bergengen L., Sandvik L., Arnesen H., Hanssen K.F., et al. Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes. Diabetologia 2005, 48:776-779.
7. Järvisalo M.J., Jartti L., Näntö-Salonen K., Irjala K., Ronnemaa T., Hartiala J.J., et al. Increased aortic intima-media thickness. A marker of preclinical atherosclerosis in high-risk children. Circulation 2001, 104:2943-2947.
8. Djaberi R., Schuijf J.D., Boersma E., Kroft L.J.M., Pereira A., Romijn J.A., et al. Differences in atherosclerotic plaque burden and morphology between type 1 and 2 diabetes as assessed by multislice computed tomography. Diabetes Care 2009, 32:1507-1512.
9. Dahl-Jørgensen K., Larsen J.R., Hanssen K.F. Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?. Diabetologia 2005, 48:1445-1453.
10. Jensen-Urstad K.J., Reichard P.G., Rosfors J.S., Lindblad L.E., Jensen-Urstad M.T. Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 1996, 45:1253-1258.
11. Anonymous Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 1995, 75:894-903.
12. Nathan D.M., Cleary P.A., Backlund J.Y., Genuth S.M., Lachin J.M., Orchard T.J., et al. Intensive diabetes treatment and cardiovascular disease in patients with type-1 diabetes. N Engl J Med 2005, 353:2643-2653. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group.
13. Koivisto V.A., Stevens L.K., Mattock M., Ebeling P., Muggeo M., Stephenson J., et al. Cardiovascular disease and its risk factors in IDDM in Europe. Diabetes Care 1996, 19:689-697. EURODIAB IDDM Complications Study Group.
14. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114(Suppl 2):555-576. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, [4th report].
15. Vergès B. Lipid disorders in type-1 diabetes. Diabetes Metab 2009, 35:353-360.
16. Rodrigues TC, Snell-Bergeon JK, Maahs DM, Kinney GL, Rewers M. Higher Fibrinogen levels predict progression of coronary artery calcification in adults with type-1 diabetes. Atherosclerosis 2010 [Epub ahead of print].
17. Grauslund J, Jørgensen TM, Nybo M, Green A, Rasmussen LM, Sjolie AK. Risk factors for mortality and ischemic heart disease in patients with long-term type-1 diabetes. J Diabetes Complications 2009 [Epub ahead of print].
18. Physical activity/exercise and diabetes mellitus. Diabetes Care 2003, 26(Suppl. 1):S73-S77. American Diabetes Association.
19. Gill G.V., Woodward A., Casson I.F., Weston P.J. Cardiac arrhythmia and nocturnal hypoglycaemia in type-1 diabetes - the 'dead in bed' syndrome revisited. Diabetologia 2009, 52:42-45.